LifeStance Health Group (NASDAQ:LFST) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 12.7% [Yahoo! Finance]
LifeStance Health Group, Inc. (LFST)
Company Research
Source: Yahoo! Finance
Guidance for next quarter's revenue was optimistic at $390 million at the midpoint, 2.4% above analysts' estimates. Its GAAP profit of $0.03 per share was significantly above analysts' consensus estimates. Is now the time to buy LifeStance Health Group? Find out in our full research report LifeStance Health Group (LFST) Q4 CY2025 Highlights: Revenue: $382.2 million vs analyst estimates of $378.6 million (17.4% year-on-year growth, 1% beat) EPS (GAAP): $0.03 vs analyst estimates of $0 (significant beat) Adjusted EBITDA: $157.7 million vs analyst estimates of $40.31 million (41.3% margin, significant beat) Revenue Guidance for Q1 CY2026 is $390 million at the midpoint, above analyst estimates of $380.9 million EBITDA guidance for the upcoming financial year 2026 is $195 million at the midpoint, above analyst estimates of $181.5 million Operating Margin: 4.7%, up from 0.3% in the same quarter last year Free Cash Flow Margin: 12.2%, down from 17.2% in the same quarter la
Show less
Read more
Impact Snapshot
Event Time:
LFST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFST alerts
High impacting LifeStance Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
LFST
News
- LifeStance Health Group (LFST) had its price target raised by Canaccord Genuity Group Inc. from $9.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- LifeStance Health Group (LFST) had its price target raised by UBS Group AG from $10.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- LifeStance Health Group (LFST) had its price target raised by KeyCorp from $8.00 to $9.00. They now have an "overweight" rating on the stock.MarketBeat
- LifeStance Health Group Announces Launch of Secondary Public OfferingGlobeNewswire
- LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
LFST
Earnings
- 2/25/26 - Beat
LFST
Sec Filings
- 2/27/26 - Form 424B7
- 2/26/26 - Form 424B7
- 2/25/26 - Form S-8
- LFST's page on the SEC website